Anders Alderborn
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmacology and Obesity Treatment
-
- Cervical Cancer and HPV Research
Papers in
- Genetics 6
- Genetic diversity and population structure 1
-
- Cervical Cancer and HPV Research 6
- Co-authors
- U. Gyllensten (1 shared paper)Monica Pettersson (1 shared paper)Hanna Andréasson (1 shared paper)Anna‐Lena Zackrisson (1 shared paper)Lars G. Engstrand (2 shared papers)Bertil Lindblom (1 shared paper)U. Pettersson (2 shared papers)Jens G. Mattsson (2 shared papers)
- Journals
- Journal of Virology (3 papers)BioTechniques (2 papers)Journal of Clinical Microbiology (2 papers)Applied and Environmental Microbiology (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- SwedenLuxembourgGermany
In The Last Decade
Anders Alderborn
27 papers receiving 731 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 77
- Epidemiology 139
- Genetics 112
- Clinical Biochemistry 18
- Infectious Diseases 67
Countries citing papers authored by Anders Alderborn
This map shows the geographic impact of Anders Alderborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Alderborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Alderborn more than expected).
Fields of papers citing papers by Anders Alderborn
This network shows the impact of papers produced by Anders Alderborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Alderborn. The network helps show where Anders Alderborn may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Alderborn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 103 | |
| 2 | Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. | 1990 | 80 |
| 3 | 2002 | 70 | |
| 4 | 2006 | 62 | |
| 5 | 2020 | 62 | |
| 6 | 2005 | 52 | |
| 7 | 2002 | 47 | |
| 8 | 2003 | 42 | |
| 9 | 2003 | 34 | |
| 10 | 2001 | 28 | |
| 11 | 1990 | 27 | |
| 12 | 2009 | 23 | |
| 13 | 2004 | 21 | |
| 14 | 1992 | 15 | |
| 15 | 2002 | 15 | |
| 16 | 2009 | 15 | |
| 17 | 2003 | 13 | |
| 18 | 2001 | 12 | |
| 19 | 2002 | 12 | |
| 20 | 2018 | 12 |
About Anders Alderborn
Anders Alderborn is a scholar working on Genetics, Epidemiology, Pharmacology, Molecular Biology and Infectious Diseases, having authored 27 papers that have together received 783 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (6 papers), Molecular Biology Techniques and Applications (3 papers), bioluminescence and chemiluminescence research (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Genomics and Phylogenetic Studies (2 papers), Genetic diversity and population structure (1 paper) and Hereditary Neurological Disorders (1 paper). The work is most often cited by research in Pharmacology (77 citations), Epidemiology (139 citations), Genetics (112 citations), Clinical Biochemistry (18 citations) and Infectious Diseases (67 citations). Anders Alderborn has collaborated with scholars based in Sweden, Luxembourg and Germany. Frequent co-authors include U. Gyllensten, Monica Pettersson, Hanna Andréasson, Anna‐Lena Zackrisson, Lars G. Engstrand, Bertil Lindblom, U. Pettersson, Jens G. Mattsson, Mia Wadelius and Agneta G Siegbahn. Their work appears in journals such as Journal of Virology, BioTechniques, Journal of Clinical Microbiology, Applied and Environmental Microbiology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.